Related Experiment Video
Updated: Jan 11, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
RIPK3 is spatially associated with cartilage degeneration in osteoarthritis: integrative transcriptomic and
Lei Wang1, Jing Tang2,3, Lei Niu2,4
1Department of Trauma and Joint Surgery, The Fifth People's Hospital of Ningxia Hui Autonomous Region, Shizuishan, 753000, Ningxia, China.
Background:
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage loss, yet its molecular underpinnings remain incompletely defined. This study aimed to investigate the regional expression pattern of receptor-interacting protein kinase 3 (RIPK3) in OA cartilage and its association with histopathological severity.
Methods:
Cartilage samples were collected from OA patients and categorized into normal tissue (NT), junction tissue (JT), and lesioned tissue (LT). RNA sequencing was performed to identify differentially expressed genes (DEGs) between NT and JT. Gene enrichment analysis was conducted to explore functional pathways. Immunofluorescence staining was used to validate RIPK3 protein expression and localization.
Results:
Transcriptomic analysis identified 140 differentially expressed genes (DEGs) between NT and JT, with several genes, including RIPK3, CCL19, and ITLN1, significantly up-regulated in JT. RIPK3 expression showed a log2 Fold Change of 2.17 (p < 0.01) and displayed higher protein abundance in LT (3.66-fold vs NT), concordant with the transcriptomic trend. This increase correlated with more severe histopathological damage (Mankin score: LT 33.0 vs. NT 5.6; OARSI score: LT 15.8 vs. NT 1.6). Functional enrichment analysis associated RIPK3 with necroptosis, immune signaling and extracellular matrix catabolism. Immunofluorescence staining confirmed spatial accumulation of RIPK3 in LT, consistent with transcriptomic data.
Conclusions:
RIPK3 is spatially enriched in degenerative regions of OA cartilage and associates with histopathological damage, suggesting its potential involvement in disease progression. These findings provide new insight into the molecular landscape of OA and support RIPK3 for further evaluation as a biomarker and potential therapeutic target.
Insights
Receptor-interacting protein kinase 3 (RIPK3) is found in damaged osteoarthritis cartilage and correlates with disease severity. This suggests RIPK3 may be a biomarker and therapeutic target for osteoarthritis progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with poorly understood molecular causes.
- Cartilage degradation is a hallmark of OA, necessitating research into its underlying molecular mechanisms.
Purpose of the Study:
- To investigate the regional expression of receptor-interacting protein kinase 3 (RIPK3) in OA cartilage.
- To determine the association between RIPK3 expression and the histopathological severity of OA.
Main Methods:
- RNA sequencing to identify differentially expressed genes (DEGs) in OA cartilage.
- Immunofluorescence staining to validate RIPK3 protein expression and localization.
- Correlation analysis between RIPK3 levels and OA histopathological scores (Mankin, OARSI).
Main Results:
- RIPK3 was significantly upregulated in lesioned OA cartilage compared to normal tissue (log2 Fold Change 2.17).
- RIPK3 protein abundance increased with disease severity, correlating with higher Mankin and OARSI scores.
- Functional enrichment analysis linked RIPK3 to necroptosis, immune signaling, and extracellular matrix degradation.
Conclusions:
- RIPK3 is spatially enriched in degenerative OA cartilage regions.
- RIPK3 expression correlates with OA histopathological damage, indicating its role in disease progression.
- RIPK3 presents potential as a biomarker and therapeutic target for osteoarthritis.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway

